Injective (INJ) is currently trading at $3.54, reflecting a notable 10.82% increase over the last 24 hours. The daily trading range is relatively tight, with a high of $3.53 and a low of $3.20, indicating moderate volatility within this period.

The trading volume stands at 102,865,498, which corresponds to a volume-to-market cap ratio of 29.13%, suggesting healthy liquidity. Short-term moving averages are all in positive territory, with the 8 SMA at $3.41 (+3.95%) and the 13 SMA at $3.38 (+4.87%), indicating a bullish trend in the immediate market context.

The 1-hour RSI is at 79, signaling potential overbought conditions, while the 7-day RSI sits at 53, indicating a balanced momentum over the week. Recent price changes show a 12.50% increase over the past week, juxtaposed against a more significant 30-day decline of 24.59%, reflecting mixed short- and long-term trends.

Despite the recent price rally, the 30-day performance suggests caution as the asset has not regained its previous highs. The all-time high of $52.62 remains significantly above the current price, indicating potential upside but also highlighting the volatility and risk inherent in the asset.

Considering the current market conditions, the bullish sentiment reflected in short-term moving averages and recent price increases is tempered by overbought signals and longer-term declines. Therefore, the recommendation is to Hold Injective (INJ) at this time, awaiting further confirmation of sustained upward momentum and a potential correction in the RSI indicators.